Treatment of Paragonimus westermani infections with bithionol.
D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002396:Catechols / Q000627:therapeutic use*; D004197:Disease Reservoirs; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use; D010237:Paragonimiasis / Q000188:drug therapy*; D010238:Paragonimus / Q000145:classification; D013045:Species Specificity
D000871:Anthelmintics; D002396:Catechols; D006846:Hydrocarbons, Halogenated